Table 2 Subject Characteristics Prior to Treatment
From: Effect of optically modified polyethylene terephthalate fiber socks on chronic foot pain
Demographics | McGill | ||||||
|---|---|---|---|---|---|---|---|
All Subjects | Age | % male | I-a | I-b | I-a+b | II | III |
Celliant™ | 57.7 ± 11.8 | 70% | 1.2 ± 0.8 | 0.6 ± 0.7 | 1.9 ± 1.5 | 4.7 ± 2.4 | 2.6 ± 1.0 |
Control | 61.6 ± 11.8 | 68% | 1.3 ± 0.7 | 1.1 ± 1.0 | 2.4 ± 1.6 | 5.4 ± 2.8 | 3.1 ± 1.1 |
DPN group | |||||||
Celliant™ | 63.0 ± 7.7 | 85% | 1.2 ± 0.9 | 0.6 ± 0.7 | 1.9 ± 1.5 | 5.1 ± 2.6 | 2.7 ± 1.1 |
Control | 63.9 ± 11.0 | 77% | 1.4 ± 0.7 | 1.2 ± 1.1 | 2.5 ± 1.7 | 5.2 ± 2.9 | 2.9 ± 0.9 |
Non-DPN group | |||||||
Celliant™ | 52.7 ± 13.1 | 57% | 1.2 ± 0.8 | 0.6 ± 0.8 | 1.9 ± 1.5 | 4.4 ± 2.3 | 2.4 ± 0.9 |
Control | 59.5 ± 12.3 | 60% | 1.3 ± 0.8 | 1.1 ± 1.0 | 2.3 ± 1.6 | 5.6 ± 2.8 | 3.3 ± 1.2 |
Brief Pain Inventory | |||||||
All Subjects | Pain Severity | Pain Interference | VAS | SF-36: Bodily Pain | |||
Celliant™ | 4.2 ± 2.4 | 5.8 ± 2.4 | 37.8 ± 8.1 | 4.2 ± 2.4 | |||
Control | 5.5 ± 2.6 | 6.4 ± 1.8 | 34.6 ± 7.8 | 5.5 ± 2.6 | |||
DPN group | |||||||
Celliant™ | 4.9 ± 2.0 | 4.7 ± 2.5 | 5.9 ± 2.4 | 34.2 ± 7.4 | |||
Control | 5.1 ± 2.3 | 5.5 ± 2.9 | 6.1 ± 1.9 | 36.1 ± 7.5 | |||
Non-DPN group | |||||||
Celliant™ | 3.9 ± 1.9* | 3.8 ± 2.3* | 5.8 ± 2.5 | 40.8 ± 7.7 | |||
Control | 5.3 ± 1.6* | 5.6 ± 2.3* | 6.6 ± 1.8 | 33.3 ± 8.1 | |||